• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

尿 ATP 可能是女性膀胱过度活动症逼尿肌过度活动的动态生物标志物。

Urinary ATP may be a dynamic biomarker of detrusor overactivity in women with overactive bladder syndrome.

机构信息

Laboratório de Farmacologia e Neurobiologia, UMIB, Instituto de Ciências Biomédicas Abel Salazar (ICBAS)-Universidade do Porto (UP), Porto, Portugal.

出版信息

PLoS One. 2013 May 31;8(5):e64696. doi: 10.1371/journal.pone.0064696. Print 2013.

DOI:10.1371/journal.pone.0064696
PMID:23741373
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3669404/
Abstract

BACKGROUND

Nowadays, there is a considerable bulk of evidence showing that ATP has a prominent role in the regulation of human urinary bladder function and in the pathophysiology of detrusor overactivity. ATP mediates nonadrenergic-noncholinergic detrusor contractions in overactive bladders. In vitro studies have demonstrated that uroepithelial cells and cholinergic nerves from overactive human bladder samples (OAB) release more ATP than controls. Here, we compared the urinary ATP concentration in samples collected non-invasively from OAB women with detrusor overactivity and age-matched controls.

METHODS

Patients with neurologic diseases, history of malignancy, urinary tract infections or renal impairment (creatinine clearance <70 ml/min) were excluded. All patients completed a 3-day voiding diary, a 24 h urine collection and blood sampling to evaluate creatinine clearance. Urine samples collected during voluntary voids were immediately freeze-preserved for ATP determination by the luciferin-luciferase bioluminescence assay; for comparison purposes, samples were also tested for urinary nerve growth factor (NGF) by ELISA.

RESULTS

The urinary content of ATP, but not of NGF, normalized to patients' urine creatinine levels (ATP/Cr) or urinary volume (ATP.Vol) were significantly (P<0.05) higher in OAB women with detrusor overactivity (n = 34) than in healthy controls (n = 30). Significant differences between the two groups were still observed by boosting urinary ATP/Cr content after water intake, but these were not detected for NGF/Cr. In OAB patients, urinary ATP/Cr levels correlated inversely with mean voided volumes determined in a 3-day voiding diary.

CONCLUSION

A high area under the receiver operator characteristics (ROC) curve (0.741; 95% CI 0.62-0.86; P<0.001) is consistent with urinary ATP/Cr being a highly sensitive dynamic biomarker for assessing detrusor overactivity in women with OAB syndrome.

摘要

背景

如今,有相当多的证据表明,ATP 在调节人类膀胱功能和逼尿肌过度活动的病理生理学方面起着重要作用。ATP 介导过度活动的膀胱中非肾上腺素能-非胆碱能逼尿肌收缩。体外研究表明,来自过度活动的人膀胱样本(OAB)的尿上皮细胞和胆碱能神经比对照释放更多的 ATP。在这里,我们比较了从患有逼尿肌过度活动的 OAB 女性和年龄匹配的对照者中非侵入性收集的尿液样本中的尿 ATP 浓度。

方法

排除患有神经疾病、恶性肿瘤病史、尿路感染或肾功能不全(肌酐清除率<70ml/min)的患者。所有患者均完成了 3 天的排尿日记、24 小时尿液收集和血液采样以评估肌酐清除率。在自愿排尿期间收集的尿液样本立即通过荧光素-荧光素酶生物发光测定法冷冻保存以测定 ATP;为了比较目的,还通过 ELISA 测定尿液神经生长因子(NGF)。

结果

与健康对照组(n=30)相比,逼尿肌过度活动的 OAB 女性(n=34)的尿 ATP 含量(但不是 NGF)归一化至患者的尿肌酐水平(ATP/Cr)或尿体积(ATP.Vol)明显更高(P<0.05)。两组之间的差异在摄入水后增加尿 ATP/Cr 含量后仍然存在,但未检测到 NGF/Cr。在 OAB 患者中,尿 ATP/Cr 水平与 3 天排尿日记中确定的平均排尿量呈负相关。

结论

高受试者工作特征曲线下面积(0.741;95%CI 0.62-0.86;P<0.001)表明尿 ATP/Cr 是评估 OAB 综合征女性逼尿肌过度活动的高度敏感的动态生物标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/560a/3669404/7d272e2d1912/pone.0064696.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/560a/3669404/6a4feaca14b7/pone.0064696.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/560a/3669404/410757d26d8e/pone.0064696.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/560a/3669404/0b7b5517fc44/pone.0064696.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/560a/3669404/94c218bca867/pone.0064696.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/560a/3669404/7d272e2d1912/pone.0064696.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/560a/3669404/6a4feaca14b7/pone.0064696.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/560a/3669404/410757d26d8e/pone.0064696.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/560a/3669404/0b7b5517fc44/pone.0064696.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/560a/3669404/94c218bca867/pone.0064696.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/560a/3669404/7d272e2d1912/pone.0064696.g005.jpg

相似文献

1
Urinary ATP may be a dynamic biomarker of detrusor overactivity in women with overactive bladder syndrome.尿 ATP 可能是女性膀胱过度活动症逼尿肌过度活动的动态生物标志物。
PLoS One. 2013 May 31;8(5):e64696. doi: 10.1371/journal.pone.0064696. Print 2013.
2
Correlation between cystometric volumes, ATP release, and pH in women with overactive bladder versus controls.在膀胱过度活动症女性与对照组中,膀胱测压容积、ATP 释放与 pH 值之间的相关性。
Neurourol Urodyn. 2013 Sep;32(7):969-73. doi: 10.1002/nau.22344. Epub 2012 Nov 5.
3
Urinary nerve growth factor levels are elevated in patients with overactive bladder and do not significantly increase with bladder distention.膀胱过度活动症患者的尿神经生长因子水平升高,且不会随膀胱扩张而显著增加。
Neurourol Urodyn. 2009;28(1):78-81. doi: 10.1002/nau.20599.
4
[NERVE GROWTH FACTOR IN THE URINE OF PATIENTS WITH IDIOPATHIC DETRUSOR OVERACTIVITY AND OVERACTIVE BLADDER WITHOUT DETRUSOR OVERACTIVITY].[特发性逼尿肌过度活动症患者及无逼尿肌过度活动症的膀胱过度活动症患者尿液中的神经生长因子]
Urologiia. 2015 May-Jun(3):19-22.
5
Nerve growth factor (NGF): a potential urinary biomarker for overactive bladder syndrome (OAB)?神经生长因子(NGF):用于诊断膀胱过度活动症(OAB)的潜在尿液生物标志物?
BJU Int. 2013 Mar;111(3):372-80. doi: 10.1111/j.1464-410X.2012.11672.x.
6
Can urinary nerve growth factor and bladder wall thickness correlation in children have a potential role to predict the outcome of non-monosymptomatic nocturnal enuresis?儿童尿神经生长因子与膀胱壁厚度的相关性能否在预测非单症状性夜间遗尿症的预后中发挥潜在作用?
J Pediatr Urol. 2015 Oct;11(5):265.e1-5. doi: 10.1016/j.jpurol.2015.03.018. Epub 2015 May 27.
7
Urinary nerve growth factor levels are increased in patients with bladder outlet obstruction with overactive bladder symptoms and reduced after successful medical treatment.膀胱出口梗阻伴膀胱过度活动症症状的患者,其尿神经生长因子水平升高,成功药物治疗后降低。
Urology. 2008 Jul;72(1):104-8; discussion 108. doi: 10.1016/j.urology.2008.01.069. Epub 2008 Apr 8.
8
Urinary brain-derived neurotrophic factor: a potential biomarker for objective diagnosis of overactive bladder.尿脑源性神经营养因子:一种用于膀胱过度活动症客观诊断的潜在生物标志物。
Int Urol Nephrol. 2014 Feb;46(2):341-7. doi: 10.1007/s11255-013-0540-x. Epub 2013 Aug 28.
9
NGF and HB-EGF: potential biomarkers that reflect the effects of fesoterodine in patients with overactive bladder syndrome.神经生长因子和肝素结合表皮生长因子:反映非索罗定对膀胱过度活动症患者疗效的潜在生物标志物。
Yonsei Med J. 2015 Jan;56(1):204-11. doi: 10.3349/ymj.2015.56.1.204.
10
Urinary nerve growth factor is a better biomarker than detrusor wall thickness for the assessment of overactive bladder with incontinence.尿神经生长因子是评估伴失禁的膀胱过度活动症的一个比逼尿肌壁厚度更好的生物标志物。
Neurourol Urodyn. 2010 Mar;29(3):482-7. doi: 10.1002/nau.20741.

引用本文的文献

1
Prostaglandins Regulate Urinary Purines by Modulating Soluble Nucleotidase Release in the Bladder Lumen.前列腺素通过调节膀胱腔内可溶性核苷酸酶的释放来调节尿嘌呤。
Int J Mol Sci. 2025 Aug 19;26(16):8023. doi: 10.3390/ijms26168023.
2
The Role of microRNA in Overactive Bladder: Relationship and Clinical Correlation.微小RNA在膀胱过度活动症中的作用:关系及临床相关性
Medicina (Kaunas). 2025 Mar 8;61(3):475. doi: 10.3390/medicina61030475.
3
Relevant markers for overactive bladder laser therapy: nitric oxide and urinary nerve growth factor.

本文引用的文献

1
Correlation between cystometric volumes, ATP release, and pH in women with overactive bladder versus controls.在膀胱过度活动症女性与对照组中,膀胱测压容积、ATP 释放与 pH 值之间的相关性。
Neurourol Urodyn. 2013 Sep;32(7):969-73. doi: 10.1002/nau.22344. Epub 2012 Nov 5.
2
Brain-derived neurotrophic factor contributes to abdominal pain in irritable bowel syndrome.脑源性神经营养因子与肠易激综合征的腹痛有关。
Gut. 2012 May;61(5):685-94. doi: 10.1136/gutjnl-2011-300265. Epub 2011 Oct 13.
3
Non-invasive techniques in the diagnosis of bladder storage disorders.
膀胱过度活动症激光治疗的相关标志物:一氧化氮和尿神经生长因子。
Lasers Med Sci. 2025 Feb 6;40(1):73. doi: 10.1007/s10103-025-04330-0.
4
Disruption of circadian rhythm as a potential pathogenesis of nocturia.昼夜节律紊乱作为夜尿症的一种潜在发病机制。
Nat Rev Urol. 2025 May;22(5):276-293. doi: 10.1038/s41585-024-00961-0. Epub 2024 Nov 14.
5
PDE5 inhibitor potentially improves polyuria and bladder storage and voiding dysfunctions in type 2 diabetic rats.PDE5 抑制剂可能改善 2 型糖尿病大鼠的多尿和膀胱储尿及排空功能障碍。
PLoS One. 2024 Sep 18;19(9):e0301883. doi: 10.1371/journal.pone.0301883. eCollection 2024.
6
Urinary ATP may be a biomarker of interstitial cystitis/bladder pain syndrome and its severity.尿 ATP 可能是间质性膀胱炎/膀胱疼痛综合征及其严重程度的生物标志物。
Biomol Biomed. 2024 Jan 3;24(1):170-175. doi: 10.17305/bb.2023.9694.
7
Mechanotransduction in the urothelium: ATP signalling and mechanoreceptors.尿路上皮的机械转导:ATP信号传导与机械感受器
Heliyon. 2023 Aug 23;9(9):e19427. doi: 10.1016/j.heliyon.2023.e19427. eCollection 2023 Sep.
8
Sensory Neurons, PIEZO Channels and PAC1 Receptors Regulate the Mechanosensitive Release of Soluble Ectonucleotidases in the Murine Urinary Bladder Lamina Propria.感觉神经元、Piezo 通道和 PAC1 受体调节小鼠膀胱固有层中可溶性核苷酸酶的机械敏感性释放。
Int J Mol Sci. 2023 Apr 15;24(8):7322. doi: 10.3390/ijms24087322.
9
Urinary ATP Levels Are Controlled by Nucleotidases Released from the Urothelium in a Regulated Manner.尿ATP水平受尿路上皮以调节方式释放的核苷酸酶控制。
Metabolites. 2022 Dec 24;13(1):30. doi: 10.3390/metabo13010030.
10
Transient receptor potential vanilloid type 4 (TRPV4) in urinary bladder structure and function.瞬时受体电位香草酸亚型 4(TRPV4)在膀胱结构和功能中的作用。
Curr Top Membr. 2022;89:95-138. doi: 10.1016/bs.ctm.2022.06.002. Epub 2022 Jul 18.
非侵入性技术在膀胱储尿功能障碍诊断中的应用。
Neurourol Urodyn. 2011 Nov;30(8):1422-8. doi: 10.1002/nau.21155. Epub 2011 Jul 20.
4
Biomarkers in overactive bladder: a new objective and noninvasive tool?膀胱过度活动症的生物标志物:一种新的客观且无创的工具?
Adv Urol. 2011;2011:382431. doi: 10.1155/2011/382431. Epub 2011 May 29.
5
Nerve growth factor in bladder dysfunction: contributing factor, biomarker, and therapeutic target.神经生长因子在膀胱功能障碍中的作用:致病因素、生物标志物和治疗靶点。
Neurourol Urodyn. 2011 Sep;30(7):1227-41. doi: 10.1002/nau.21022. Epub 2011 Apr 21.
6
The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS.在英国和瑞典,过度膀胱活动症对精神健康、工作生产力和健康相关生活质量的影响:EpiLUTS 的结果。
BJU Int. 2011 Nov;108(9):1459-71. doi: 10.1111/j.1464-410X.2010.10013.x. Epub 2011 Mar 3.
7
Urodynamic results and clinical outcomes with intradetrusor injections of onabotulinumtoxinA in a randomized, placebo-controlled dose-finding study in idiopathic overactive bladder.在特发性过度活动膀胱的一项随机、安慰剂对照剂量发现研究中,经尿道内注射肉毒毒素 A 治疗的尿动力学结果和临床结局。
Neurourol Urodyn. 2011 Apr;30(4):556-62. doi: 10.1002/nau.21021. Epub 2011 Feb 23.
8
Novel biomarkers for overactive bladder.用于治疗膀胱过度活动症的新型生物标志物。
Nat Rev Urol. 2011 Mar;8(3):139-45. doi: 10.1038/nrurol.2011.7. Epub 2011 Feb 15.
9
Therapeutic potential of purinergic signalling for diseases of the urinary tract.嘌呤能信号在治疗泌尿道疾病中的潜力。
BJU Int. 2011 Jan;107(2):192-204. doi: 10.1111/j.1464-410X.2010.09926.x.
10
Urinary nerve growth factor levels in overactive bladder syndrome and lower urinary tract disorders.尿神经生长因子水平与膀胱过度活动症及下尿路疾病。
J Formos Med Assoc. 2010 Dec;109(12):862-78. doi: 10.1016/S0929-6646(10)60133-7.